Cargando…
Nomograms based on SUVmax of (18)F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma
BACKGROUND: The prognostic value of (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma (ENKTL) is not well established. We aimed to develop nomograms for individualized estimates of progression-free survival (PFS) and overall survival (OS) in patients with ENKTL using (18)F-FDG PET/CT par...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796613/ https://www.ncbi.nlm.nih.gov/pubmed/33419476 http://dx.doi.org/10.1186/s40644-020-00379-y |
_version_ | 1783634721191755776 |
---|---|
author | Li, Hongyan Shao, Guozhu Zhang, Yajing Chen, Xiaomin Du, Chengcheng Wang, Kun Gao, Zairong |
author_facet | Li, Hongyan Shao, Guozhu Zhang, Yajing Chen, Xiaomin Du, Chengcheng Wang, Kun Gao, Zairong |
author_sort | Li, Hongyan |
collection | PubMed |
description | BACKGROUND: The prognostic value of (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma (ENKTL) is not well established. We aimed to develop nomograms for individualized estimates of progression-free survival (PFS) and overall survival (OS) in patients with ENKTL using (18)F-FDG PET/CT parameters and clinical parameters. METHODS: A total of 171 patients with newly diagnosed ENKTL undergoing (18)F-FDG PET/CT scanning were retrospectively analyzed. Nomograms were constructed according to multivariate Cox proportional hazards regression. The predictive and discriminatory capacities of the nomograms were then measured using the concordance index (C-index), calibration plots, and Kaplan-Meier curves. The C-index, the area under receiver operating characteristic (ROC) curve (AUC), and decision curve analysis (DCA) were used to contrast the predictive and discriminatory capacities of the nomograms against with the International Prognostic Index (IPI) and Korean Prognostic Index (KPI). RESULTS: Multivariate analysis demonstrated that pretreatment SUVmax≥9.5, disease stage II and III-IV, elevated lactate dehydrogenase (LDH), and elevated β2-microglobulin (β2-MG) had the strongest association with unfavorable PFS and OS. In addition, hemoglobin (Hb) < 120 g/L had a tendency to be associated with PFS. Both nomogram models incorporated SUVmax, Ann Arbor stage, LDH, and β2-MG. The PFS nomogram also included Hb. The nomograms showed good prediction accuracies, with the C-indexes for PFS and OS were 0.729 and 0.736, respectively. The calibration plots for 3-year and 5-year PFS/OS reported good consistency between predicted and observed probabilities for survival time. The PFS and OS were significantly different according to tertiles of nomogram scores (p < 0.001). The C-index and AUCs of the nomograms were higher than that of IPI and KPI. Moreover, DCA showed that the predictive accuracy of the nomograms for PFS and OS were both higher than that of IPI and KPI. CONCLUSIONS: This study established nomograms that incorporate pretreatment SUVmax and clinical parameters, which could be effective tools for individualized prognostication of both PFS and OS in patients with newly diagnosed ENKTL. |
format | Online Article Text |
id | pubmed-7796613 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-77966132021-01-11 Nomograms based on SUVmax of (18)F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma Li, Hongyan Shao, Guozhu Zhang, Yajing Chen, Xiaomin Du, Chengcheng Wang, Kun Gao, Zairong Cancer Imaging Research Article BACKGROUND: The prognostic value of (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma (ENKTL) is not well established. We aimed to develop nomograms for individualized estimates of progression-free survival (PFS) and overall survival (OS) in patients with ENKTL using (18)F-FDG PET/CT parameters and clinical parameters. METHODS: A total of 171 patients with newly diagnosed ENKTL undergoing (18)F-FDG PET/CT scanning were retrospectively analyzed. Nomograms were constructed according to multivariate Cox proportional hazards regression. The predictive and discriminatory capacities of the nomograms were then measured using the concordance index (C-index), calibration plots, and Kaplan-Meier curves. The C-index, the area under receiver operating characteristic (ROC) curve (AUC), and decision curve analysis (DCA) were used to contrast the predictive and discriminatory capacities of the nomograms against with the International Prognostic Index (IPI) and Korean Prognostic Index (KPI). RESULTS: Multivariate analysis demonstrated that pretreatment SUVmax≥9.5, disease stage II and III-IV, elevated lactate dehydrogenase (LDH), and elevated β2-microglobulin (β2-MG) had the strongest association with unfavorable PFS and OS. In addition, hemoglobin (Hb) < 120 g/L had a tendency to be associated with PFS. Both nomogram models incorporated SUVmax, Ann Arbor stage, LDH, and β2-MG. The PFS nomogram also included Hb. The nomograms showed good prediction accuracies, with the C-indexes for PFS and OS were 0.729 and 0.736, respectively. The calibration plots for 3-year and 5-year PFS/OS reported good consistency between predicted and observed probabilities for survival time. The PFS and OS were significantly different according to tertiles of nomogram scores (p < 0.001). The C-index and AUCs of the nomograms were higher than that of IPI and KPI. Moreover, DCA showed that the predictive accuracy of the nomograms for PFS and OS were both higher than that of IPI and KPI. CONCLUSIONS: This study established nomograms that incorporate pretreatment SUVmax and clinical parameters, which could be effective tools for individualized prognostication of both PFS and OS in patients with newly diagnosed ENKTL. BioMed Central 2021-01-08 /pmc/articles/PMC7796613/ /pubmed/33419476 http://dx.doi.org/10.1186/s40644-020-00379-y Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Li, Hongyan Shao, Guozhu Zhang, Yajing Chen, Xiaomin Du, Chengcheng Wang, Kun Gao, Zairong Nomograms based on SUVmax of (18)F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma |
title | Nomograms based on SUVmax of (18)F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma |
title_full | Nomograms based on SUVmax of (18)F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma |
title_fullStr | Nomograms based on SUVmax of (18)F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma |
title_full_unstemmed | Nomograms based on SUVmax of (18)F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma |
title_short | Nomograms based on SUVmax of (18)F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma |
title_sort | nomograms based on suvmax of (18)f-fdg pet/ct and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/t-cell lymphoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796613/ https://www.ncbi.nlm.nih.gov/pubmed/33419476 http://dx.doi.org/10.1186/s40644-020-00379-y |
work_keys_str_mv | AT lihongyan nomogramsbasedonsuvmaxof18ffdgpetctandclinicalparametersforpredictingprogressionfreeandoverallsurvivalinpatientswithnewlydiagnosedextranodalnaturalkillertcelllymphoma AT shaoguozhu nomogramsbasedonsuvmaxof18ffdgpetctandclinicalparametersforpredictingprogressionfreeandoverallsurvivalinpatientswithnewlydiagnosedextranodalnaturalkillertcelllymphoma AT zhangyajing nomogramsbasedonsuvmaxof18ffdgpetctandclinicalparametersforpredictingprogressionfreeandoverallsurvivalinpatientswithnewlydiagnosedextranodalnaturalkillertcelllymphoma AT chenxiaomin nomogramsbasedonsuvmaxof18ffdgpetctandclinicalparametersforpredictingprogressionfreeandoverallsurvivalinpatientswithnewlydiagnosedextranodalnaturalkillertcelllymphoma AT duchengcheng nomogramsbasedonsuvmaxof18ffdgpetctandclinicalparametersforpredictingprogressionfreeandoverallsurvivalinpatientswithnewlydiagnosedextranodalnaturalkillertcelllymphoma AT wangkun nomogramsbasedonsuvmaxof18ffdgpetctandclinicalparametersforpredictingprogressionfreeandoverallsurvivalinpatientswithnewlydiagnosedextranodalnaturalkillertcelllymphoma AT gaozairong nomogramsbasedonsuvmaxof18ffdgpetctandclinicalparametersforpredictingprogressionfreeandoverallsurvivalinpatientswithnewlydiagnosedextranodalnaturalkillertcelllymphoma |